scholarly journals CRISPR systems: what’s new, where next?

2021 ◽  
Author(s):  
Ashley Parkes ◽  
Fiona Kemm ◽  
Liu He ◽  
Tom Killelea
Keyword(s):  
Dna Repair ◽  
Immune System ◽  
Genetic Engineering ◽  
Gene Editing ◽  
Adaptive Immune System ◽  
Feature Article ◽  
Adaptive Immune ◽  
The Past ◽  
Domains Of Life ◽  
Made In

The genetic signature of natural CRISPR-Cas systems were first noted in a 1989 publication and were characterized in detail from 2002 to 2007, culminating in the first report of a prokaryotic adaptive immune system. Since then, CRISPR-Cas enzymes have been adapted into molecular biology tools that have transformed genetic engineering across domains of life. In this feature article, we describe origins, uses and futures of CRISPR-Cas enzymes in genetic engineering: we highlight advances made in the past 10 years. Central to these advances is appreciation of interplay between CRISPR engineering and DNA repair. We highlight how this relationship has been manipulated to create further advances in the development of gene editing.

Repurposing CRISPR-Cas Systems as Genetic Tools for the Enterobacteriales

EcoSal Plus ◽  
2021 ◽  
Author(s):  
Nicholas Backes ◽  
Gregory J. Phillips
Keyword(s):  
Gene Regulation ◽  
Immune System ◽  
Gene Editing ◽  
Defense Mechanism ◽  
Adaptive Immune System ◽  
Plasmid Curing ◽  
Genetic Tools ◽  
Adaptive Immune ◽  
Domains Of Life ◽  
Eukaryotic Genomes

Over the last decade, the study of CRISPR-Cas systems has progressed from a newly discovered bacterial defense mechanism to a diverse suite of genetic tools that have been applied across all domains of life. While the initial applications of CRISPR-Cas technology fulfilled a need to more precisely edit eukaryotic genomes, creative “repurposing” of this adaptive immune system has led to new approaches for genetic analysis of microorganisms, including improved gene editing, conditional gene regulation, plasmid curing and manipulation, and other novel uses.

scholarly journals CRISPR technology a silver lining in combating COVID-19 pandemic

2021 ◽  
pp. 18-21
Author(s):  
Ritesh Kumar Shukla ◽  
N Venkat Appa Rao
Keyword(s):  
Immune System ◽  
Genetic Engineering ◽  
Rapid Detection ◽  
Life Sciences ◽  
Genetic Material ◽  
Adaptive Immune System ◽  
Adaptive Immune ◽  
Life Threatening ◽  
Evolution Of Science ◽  
Silver Lining

Technological advancements have trigged the research arena of life sciences. This has resulted not only in the co-evolution of science and technology but also in building up novel ways to tackle life threatening pandemic like situations. The use of CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) technology in combating the recent COVID-19 pandemic is evidence to this. The technique was originally identified as a microbial adaptive immune system, in which the microbes use RNA-guided nucleases to cleave foreign genetic material. Subsequently, molecular biologists started harvesting this technique in accelerating the genetic engineering/ chimeric DNA methods. During COVID-19 outbreak, the scientists are trying to mould the CRISPR technology in the successful and rapid detection of the virus and also in the treatment of COVID- 19 infection. Thus the application of this technique comes as a ray of hope not only for fighting against COVID but also can be used as weapon for unseen future pandemics.

scholarly journals Harnessing the CRISPR-Cas Systems to Combat Antimicrobial Resistance

2021 ◽  
Vol 12 ◽  
Author(s):  
Cheng Duan ◽  
Huiluo Cao ◽  
Lian-Hui Zhang ◽  
Zeling Xu
Keyword(s):  
Immune System ◽  
Antimicrobial Resistance ◽  
Global Health ◽  
Adaptive Immune System ◽  
Type I ◽  
Type Ii ◽  
Bacterial Genomes ◽  
Adaptive Immune ◽  
The Past ◽  
Attractive Option

The emergence of antimicrobial-resistant (AMR) bacteria has become one of the most serious threats to global health, necessitating the development of novel antimicrobial strategies. CRISPR (clustered regularly interspaced short palindromic repeats)-Cas (CRISPR-associated) system, known as a bacterial adaptive immune system, can be repurposed to selectively target and destruct bacterial genomes other than invasive genetic elements. Thus, the CRISPR-Cas system offers an attractive option for the development of the next-generation antimicrobials to combat infectious diseases especially those caused by AMR pathogens. However, the application of CRISPR-Cas antimicrobials remains at a very preliminary stage and numerous obstacles await to be solved. In this mini-review, we summarize the development of using type I, type II, and type VI CRISPR-Cas antimicrobials to eradicate AMR pathogens and plasmids in the past a few years. We also discuss the most common challenges in applying CRISPR-Cas antimicrobials and potential solutions to overcome them.

scholarly journals CRISPR/Cas System and Factors Affecting Its Precision and Efficiency

2021 ◽  
Vol 9 ◽  
Author(s):  
Nasir Javaid ◽  
Sangdun Choi
Keyword(s):  
Dna Repair ◽  
Immune System ◽  
Genome Editing ◽  
Defense Mechanism ◽  
Adaptive Immune System ◽  
Host Cells ◽  
Factors Affecting ◽  
Editing Efficiency ◽  
Adaptive Immune ◽  
Repair Pathways

The diverse applications of genetically modified cells and organisms require more precise and efficient genome-editing tool such as clustered regularly interspaced short palindromic repeats/CRISPR-associated protein (CRISPR/Cas). The CRISPR/Cas system was originally discovered in bacteria as a part of adaptive-immune system with multiple types. Its engineered versions involve multiple host DNA-repair pathways in order to perform genome editing in host cells. However, it is still challenging to get maximum genome-editing efficiency with fewer or no off-targets. Here, we focused on factors affecting the genome-editing efficiency and precision of CRISPR/Cas system along with its defense-mechanism, orthologues, and applications.

Evolution and age characteristics of the innate and adaptive immune system

2016 ◽  
Vol 75 (3) ◽  
pp. 74-84 ◽  
Author(s):  
A.E. Abaturov ◽  
◽  
E.A. Agafonova ◽  
N.I. Abaturova ◽  
V.L. Babich ◽  
...  
Keyword(s):  
Immune System ◽  
Adaptive Immune System ◽  
Adaptive Immune

scholarly journals Exploiting DNA Endonucleases to Advance Mechanisms of DNA Repair

Biology ◽  
2021 ◽  
Vol 10 (6) ◽  
pp. 530
Author(s):  
Marlo K. Thompson ◽  
Robert W. Sobol ◽  
Aishwarya Prakash
Keyword(s):  
Dna Repair ◽  
Mammalian Cells ◽  
Genome Stability ◽  
Gene Editing ◽  
Adaptive Immune System ◽  
Zinc Finger Nucleases ◽  
Specific Gene ◽  
Target Sequence ◽  
Transcription Activator ◽  
Low Cytotoxicity

The earliest methods of genome editing, such as zinc-finger nucleases (ZFN) and transcription activator-like effector nucleases (TALENs), utilize customizable DNA-binding motifs to target the genome at specific loci. While these approaches provided sequence-specific gene-editing capacity, the laborious process of designing and synthesizing recombinant nucleases to recognize a specific target sequence, combined with limited target choices and poor editing efficiency, ultimately minimized the broad utility of these systems. The discovery of clustered regularly interspaced short palindromic repeat sequences (CRISPR) in Escherichia coli dates to 1987, yet it was another 20 years before CRISPR and the CRISPR-associated (Cas) proteins were identified as part of the microbial adaptive immune system, by targeting phage DNA, to fight bacteriophage reinfection. By 2013, CRISPR/Cas9 systems had been engineered to allow gene editing in mammalian cells. The ease of design, low cytotoxicity, and increased efficiency have made CRISPR/Cas9 and its related systems the designer nucleases of choice for many. In this review, we discuss the various CRISPR systems and their broad utility in genome manipulation. We will explore how CRISPR-controlled modifications have advanced our understanding of the mechanisms of genome stability, using the modulation of DNA repair genes as examples.

Sign in / Sign up

Export Citation Format

Share Document